Quinazoline derivatives which promote the release of parathyroid hormone

Details for Australian Patent Application No. 2002325242 (hide)

Owner Novartis AG

Inventors Beerli, Rene; Widler, Leo; Weiler, Sven; Tommasi, Ruben Alberto

Agent Davies Collison Cave

Pub. Number AU-B-2002325242

PCT Number PCT/EP02/06606

PCT Pub. Number WO2002/102782

Priority 0114702.4 15.06.01 GB; 0114701.6 15.06.01 GB

Filing date 14 June 2002

Wipo publication date 2 January 2003

Acceptance publication date 9 November 2006

International Classifications

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 0114702.4 15.06.01 GB; 0114701.6 15.06.01 GB

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002325242

9 November 2006 Application Accepted

  Published as AU-B-2002325242

8 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325243-METHOD FOR PRODUCING GAS DIFFUSION ELECTRODES

2002325241-METHOD AND NUCLEIC ACIDS FOR THE DIFFERENTIATION OF PROSTATE AND RENAL CARCINOMAS